Terms: = Germ cell tumor AND CDX2, CDX3, 1045, ENSG00000165556, Q99626
194 results:
1. PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms.
Grass A; Kasajima A; Foersch S; Kriegsmann M; Brobeil A; Schmitt M; Wagner D; Poppinga J; Wiese D; Maurer E; Kirschbaum A; Muley T; Winter H; Rinke A; Gress TM; Kremer M; Evert M; Märkl B; Quaas A; Eckstein M; Tschurtschenthaler M; Klöppel G; Denkert C; Bartsch DK; Jesinghaus M
Mod Pathol; 2024 Apr; 37(4):100442. PubMed ID: 38309431
[TBL] [Abstract] [Full Text] [Related]
2. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
Bräutigam K; Chouchane A; Konukiewitz B; Perren A
Pathologie (Heidelb); 2024 Feb; 45(1):35-41. PubMed ID: 38175232
[TBL] [Abstract] [Full Text] [Related]
3. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine tumors.
Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis.
Cox AJ; Crowe WE; Yang Q; Zhang B; Oltvai ZN; Liao X
Mod Pathol; 2023 Nov; 36(11):100295. PubMed ID: 37517480
[TBL] [Abstract] [Full Text] [Related]
5. A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation.
Song X; Xie Y; Lou Y
BMC Gastroenterol; 2023 Jul; 23(1):238. PubMed ID: 37452300
[TBL] [Abstract] [Full Text] [Related]
6. Cauda Equina Neuroendocrine tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
[TBL] [Abstract] [Full Text] [Related]
7. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes.
Rothrock AT; Hameed N; Cho WC; Nagarajan P; Ivan D; Torres-Cabala CA; Prieto VG; Curry JL; Aung PP
J Cutan Pathol; 2023 Mar; 50(3):223-229. PubMed ID: 36377266
[TBL] [Abstract] [Full Text] [Related]
8. Merkel cell carcinoma of the anorectum: a case report and review of the literature.
van Wyk AC; Moolla Z; Motala AI; Roberts R; Chotey NA; Lakhi HI; Becker JC
Clin J Gastroenterol; 2022 Aug; 15(4):740-745. PubMed ID: 35764912
[TBL] [Abstract] [Full Text] [Related]
9. Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin.
Depoilly T; Leroux R; Andrade D; Nicolle R; Dioguardi Burgio M; Marinoni I; Dokmak S; Ruszniewski P; Hentic O; Paradis V; De Mestier L; Perren A; Couvelard A; Cros J
Mod Pathol; 2022 Nov; 35(11):1713-1722. PubMed ID: 35739266
[TBL] [Abstract] [Full Text] [Related]
10. Yolk Sac tumor Originating From Cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
[TBL] [Abstract] [Full Text] [Related]
11. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
[TBL] [Abstract] [Full Text] [Related]
12. Appendiceal Well-Differentiated Neuroendocrine tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry.
Shibahara Y; Krzyzanowska M; Vajpeyi R
Int J Surg Pathol; 2023 May; 31(3):252-259. PubMed ID: 35491663
[No Abstract] [Full Text] [Related]
13. Clinicopathological observation of mature teratoma with malignant transformation, a single center retrospective study.
Yuan Y; Li H; Yang H
Indian J Pathol Microbiol; 2022; 65(2):369-373. PubMed ID: 35435373
[TBL] [Abstract] [Full Text] [Related]
14. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
[TBL] [Abstract] [Full Text] [Related]
15. cdx2 expression in malignant peripheral nerve sheath tumour: a potential diagnostic pitfall associated with PRC2 inactivation.
Odeyemi OO; Ozawa MG; Charville GW
Histopathology; 2022 May; 80(6):995-1000. PubMed ID: 35122289
[TBL] [Abstract] [Full Text] [Related]
16. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
Inzani F; Angelico G; Santoro A; Travaglino A; Insabato L; Raffone A; Arciuolo D; Scaglione G; D'Alessandris N; Valente M; Carlino A; Rindi G; Zannoni GF
Virchows Arch; 2022 Apr; 480(4):873-877. PubMed ID: 35091815
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
18. Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large cell Neuroendocrine Carcinoma with a Diagnostic Pitfall.
Inoue H; Matsushima J; Kobayashi S; Sairenchi T; Hirata H; Chida M; Ota S; Ban S; Matsumura Y
Int J Surg Pathol; 2022 Apr; 30(2):151-159. PubMed ID: 34913369
[TBL] [Abstract] [Full Text] [Related]
19. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases.
Chen I; Zhang D; Velez M; Kovar S; Liao X
Pathol Res Pract; 2021 Oct; 226():153614. PubMed ID: 34555651
[TBL] [Abstract] [Full Text] [Related]
20. Somatic-Type Yolk Sac tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
[Next]
